Quercitrin

Quercitrin

SCHEMBL3206092

C[C@@H]1OC(Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@H](O)[C@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 7/20 1.00
KDM4E B2RXH2 6/20 1.00
L3MBTL1 Q9Y468 4/20 1.00
MAOA P21397 4/20 1.00
EPHX2 P34913 4/20 1.00
XDH P47989 4/20 1.00
SLCO2B1 O94956 4/20 1.00
AKR1B1 P15121 3/20 1.00
PIM2 Q9P1W9 2/20 1.00
ALDH1A1 P00352 2/20 1.00
CA12 O43570 2/20 1.00
CA2 P00918 2/20 1.00
CA4 P22748 2/20 1.00
CA7 P43166 2/20 1.00
NQO2 P16083 1/20 0.85
MAPT P10636 5/20 0.84
POLB P06746 4/20 0.84
GAA P10253 4/20 0.84
KDM1A O60341 2/20 0.84
HMGB1 P09429 2/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quercitrin SCHEMBL29454400 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL117644 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL5456136 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL4227921 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL17628907 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL811472 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL6849807 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL15337986 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL1697151 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2
Quercitrin SCHEMBL29381705 1.00 P4HB (1.00) P4HBKDM4EL3MBTL1MAOAEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040213829-A1 Dietary supplement COLEMAN HENRY D (US) 2004-10-28 US claimed
US-20030194453-A1 Dietary supplement COLEMAN HENRY D (US) 2003-10-16 US claimed
US-20240293600-A1 COMPOSITIONS, METHODS, AND DEVICES FOR SUSTAINED RELEASE OF AN AGENT BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2024-09-05 US disclosed
EP-3746006-B1 METHODS AND DEVICES FOR REDUCING VASCULAR SMOOTH MUSCLE CELL PROLIFERATION THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2024-06-26 EP disclosed
US-12011508-B2 Methods and devices for reducing vascular smooth muscle cell proliferation BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2024-06-18 US disclosed
EP-4359026-A1 COMPOSITIONS, METHODS, AND DEVICES FOR SUSTAINED RELEASE OF AN AGENT Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) 2024-05-01 EP disclosed
WO-2022272243-A1 COMPOSITIONS, METHODS, AND DEVICES FOR SUSTAINED RELEASE OF AN AGENT BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2022-12-29 WO disclosed
CN-108138199-B Plants containing low copy number of RI gene 克鲁德简普森花卉公司 2022-01-21 CN disclosed
US-20210106728-A1 METHODS AND DEVICES FOR REDUCING VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2021-04-15 US disclosed
EP-3746006-A1 METHODS AND DEVICES FOR REDUCING VACULAR SMOOTH MUSCLE CELL PROLIFERATION The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College (US) 2020-12-09 EP disclosed
CN-111970999-A Method and device for reducing proliferation of vascular smooth muscle cells 路易斯安那州立大学和农业机械学院监事会 2020-11-20 CN disclosed
US-20060099239-A1 Dietary supplement for promoting removal of heavy metals from the body COLEMAN HENRY D 2006-05-11 US disclosed
US-20050271600-A1 Fiber supplement COLEMAN HENRY D 2005-12-08 US disclosed
US-20040213829-A1 Dietary supplement COLEMAN HENRY D (US) 2004-10-28 US disclosed
EP-1263300-B1 IMPROVEMENTS IN OR RELATING TO SOLUBILISATION OF FLAVONOLS HOWARD FOUNDATION HOLDINGS LTD (GB) 2004-10-06 EP disclosed
US-20030194453-A1 Dietary supplement COLEMAN HENRY D (US) 2003-10-16 US disclosed
WO-2003077930-A1 USE OF AT LEAST ONE QUERCETINE FLAVONOID FOR INCREASING THE LEVEL OF USEFUL SHORT-CHAIN FATTY ACIDS IN THE LOWER INTESTINAL TRACT G.O.T. THERAPEUTICS GMBH (DE) 2003-09-25 WO disclosed
US-6569446-B1 Mixing with an anthocyanin composition THE HOWARD FOUNDATION (GB) 2003-05-27 US disclosed
EP-1263300-A1 IMPROVEMENTS IN OR RELATING TO SOLUBILISATION OF FLAVONOLS Howard, Alan Norman (GB) 2002-12-11 EP disclosed
WO-2001060179-A1 IMPROVEMENTS IN OR RELATING TO SOLUBILISATION OF FLAVONOLS HOWARD ALAN NORMAN (GB) 2001-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210106728-A1 METHODS AND DEVICES FOR REDUCING VASCULAR SMOOTH MUSCLE CELL PROLIFERATION VCAM1, MYLK, TNNC1 P4HB 4334/4885KDM4E 1350/4885L3MBTL1 3939/4885
US-12011508-B2 Methods and devices for reducing vascular smooth muscle cell proliferation VCAM1, MYLK, TNNC1 P4HB 4334/4885KDM4E 1350/4885L3MBTL1 3939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.